BioProcess International™ China
Would you like to save this topic, event, protocol or job so you can find it again easily?
Just click the "Save to My Lab Drawer" link and the item will be saved in the My Lab Drawer section of your bench space.
Available to members only. Please log in or register for your free account now.
BioProcess International™ China
Aug 21, 2012 - Aug 23, 2012
Event Type: Conference
| Time: |
Aug 21, 2012 23:00 - Aug 23, 2012 7:00
|
Make sure to select correct standard or daylight time zone for your location on this event date
|
Location: Grand Hyatt Shanghai
Registration Deadline: None
Abstract Submission Deadline: None
Description of event:
At IBC's 4th Annual BioProcess International™ China event, the goal is to bring China and the rest of the world together to explore the missing gaps in China's development, and to help bring China up-to-speed on critical areas such as cell line engineering, media development, analytical characterization strategies to establish similarity between a biosimilar and its originator drug, as well as design of multi-product facilities and implementation of single-use systems.
- Cell Line Engineering, Cell Culture and Media Development
- Analytical Characterization, Comparability and Quality Assessment
- Downstream Processing and Viral Safety
- Single-Use Systems and Multi-Product Facilities
- Biosimilars Development - Regulatory and Market Challenges
- Experts from US and Europe with proven success stories
- Access to international service providers
- Facilitated networking
- Tactical strategies for informed decision making
New This Year! Hear from:
- Pfizer who will explore innovative solutions to streamline cell culture development platform process
- Henlius Biopharmaceuticals who will share their strategy from cell line development to filing IND for a biosimilar in less than 2 years
- Genentech who will take on comparability assessment for clinical development and post-approval CMC changes
- Novartis who will compare HPLC, CE, Mass Spec., NMR and other analytical technologies in the characterization of biological products
- Phage Pharmaceuticals who will detail the design of a multi-product, multi-phases, and multi-users cGMP facility
- Biocon India who will outline their low risk, flexible plant approach using single-use systems
Don't miss this opportunity to witness and partake in China's phenomenal growth! Get insider information and proven strategies to help increase your yield, improve your quality while ensuring efficiency of production and reducing manufacturing cost.
Uploaded Image:
|
Become a member & join our
community (It's easy & free)
Already a member? Please log in
Event Coordinators
List your events for free
|